Cyclosporin combined with methotrexate in two patients with recalcitrant subacute cutaneous lupus erythematosus

Australasian Journal of Dermatology

Volumn 52, Issue 1, 2011, Pages 43-47

  Klein, Annette ^a   Vogt, Thomas ^b   Wenzel, Sabrina M ^a   Fleck, Martin ^a,c   Landthaler, Michael ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c Asklepios Clinic   (Germany)

Author keywords

Cutaneous lupus; Subacute lupus erythematosus; Vasculitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; C REACTIVE PROTEIN; CLOBETASONE; COLLAGEN FIBER; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIFLUCORTOLONE; FOLIC ACID; GLUTAMIC ACID; HYDROXYCHLOROQUINE; METHOTREXATE; METHYLPREDNISOLONE; MUCIN; RHEUMATOID FACTOR; RO ANTIBODY; SUNSCREEN; TRIAMCINOLONE; UREA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; BACK; CASE REPORT; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DERMIS; DERMOEPIDERMAL JUNCTION; DISEASE CONTROL; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; ELEVATOR MUSCLE PARALYSIS; EPIDERMIS; ERYTHEMA; FACE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KERATOSIS; LIMB DYSESTHESIA; LIVEDO RETICULARIS; LIVER TOXICITY; LYMPHOCYTIC INFILTRATION; MAINTENANCE DRUG DOSE; NAUSEA; NECK; NEPHROTOXICITY; PARALYSIS; PERIODIC ACID SCHIFF STAIN; PHOTOSENSITIVITY; POLYARTERITIS NODOSA; POLYNEUROPATHY; PROTEIN BLOOD LEVEL; PUNCH BIOPSY; RADIATION PROTECTION; REMISSION; REPEAT PROCEDURE; SIDE EFFECT; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS; SUBCUTANEOUS FAT; SUN EXPOSURE; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TOPICAL TREATMENT; TREATMENT DURATION; ULTRAVIOLET RADIATION; UREA BLOOD LEVEL; URINALYSIS; VASCULITIS; VITAMIN SUPPLEMENTATION;

ADULT; CYCLOSPORINE; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; METHOTREXATE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 79952064309     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2010.00689.x     Document Type: Article

References (22)

1. Gerards AH, Landewé RBM, Prins AP et al. Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial. Ann. Rheum. Dis. 2003; 62: 291-6. (Pubitemid 36363432)
2. Tugwell P, Pincus T, Yocum D et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N. Engl. J. Med. 1995; 333: 137-41.
3. Clark CM, Kirby B, Morris AD et al. Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis. Br. J. Dermatol. 1999; 141: 279-82. (Pubitemid 29397996)
4. Aydin F, Canturk T, Senturk N et al. Methotrexate and ciclosporin combination for the treatment of severe psoriasis. Clin. Exp. Dermatol. 2006; 31: 520-4. (Pubitemid 43806583)
5. Storb R, Deeg HJ, Pepe M et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukaemia: long-term follow-up of a controlled trial. Blood 1989; 73: 1729-34. (Pubitemid 19131924)
6. Stavropoulos PG, Goules AV, Avgerinou G et al. Pathogenesis of subacute cutaneous lupus erythematosus. J. Eur. Acad. Dermatol. Venereol. 2008; 22: 1281-9.
7. Norris DA, Lee LA. Antibody-dependent cellular cytotoxicity and skin disease. J. Invest. Dermatol. 1985; 85: 165-75s.
8. Norris DA, Ryan SB, Kissinger RM et al. Systematic comparison of antibody-mediated mechanisms of keratinocyte lysis in vitro. J. Immunol. 1985; 135: 1073-79. (Pubitemid 16242800)
9. Wenzel J, Zahn S, Mikus S et al. The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets. Br. J. Dermatol. 2007; 157: 752-7. (Pubitemid 47389912)
10. Kochevar IE. Action spectrum and mechanisms of UV radiation-induced injury in lupus erythematosus. J. Invest. Dermatol. 1985; 85: 140-3s.
11. Bennion SD, Norris DA. Ultraviolet light modulation of autoantigens, epidermal cytokines and adhesion molecules as contributing factors of the pathogenesis of cutaneous LE. Lupus 1997; 6: 181-92. (Pubitemid 27102046)
12. Middleton MH, Norris DA. Cytokine-induced ICAM-1 expression in human keratinocytes is highly variable in keratinocyte strains from different donors. J. Invest. Dermatol. 1995; 104: 489-96.
13. Letellier E, Longhurst H, Diaz-Cano SJ et al. Polyarteritis nodosa developing after discoid lupus erythematosus. Clin. Exp. Rheumatol. 2001; 19: 738-9. (Pubitemid 34026843)
14. Wenzel J, Bieber T, Uerlich M et al. [Systemic treatment of cutaneous lupus erythematosus]. J. Dtsch. Dermatol. Ges. 2003; 1: 694-704. (In German.)
15. Risselada AP, Kallenberg CGM. Therapy-resistant lupus skin disease successfully treated with rituximab. Rheumatology 2006; 45: 915-16. (Pubitemid 43985387)
16. Uthman I, Taher A, Abbas O et al. Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case. Dermatology 2008; 216: 257-9. (Pubitemid 351416730)
17. Hamprecht A, Tueting T, Bieber T Wenzel J. Successful treatment of recalcitrant malar rash in a patient with cutaneous lupus erythematosus with efalizumab. Clin. Exp. Dermatol. 2008; 33: 347-8. (Pubitemid 351550639)
18. Wessels JA, Huizinga TW, Guchelaar HJ. Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology 2008; 47: 249-55. (Pubitemid 351267187)
19. Dalrymple JM, Stamp LK, O'Donnell JL et al. Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 2008; 58: 3299-308.
20. Stein CM, Brooks RH, Pincus T. Effect of combination therapy with cyclosporine and methotrexate on liver function test results in rheumatoid arthritis. Arthritis Rheum. 1997; 40: 1721-3.
21. Bejarano V, Conaghan PG, Proudman SM et al. Long-term effi- cacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis. Ann. Rheum. Dis. 2009; 68: 761-3.
22. Taylor WJ, Korendowych E, Nash P et al. Drug use and toxicity in psoriatic disease: focus on methotrexate. J. Rheumatol. 2008; 35: 1454-7. (Pubitemid 352000803)